Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2018-12-18
DOI
10.1080/09553002.2018.1558299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
- (2018) Milica Momcilovic et al. CANCER CELL
- Recent Development of Small Molecule Glutaminase Inhibitors
- (2018) Minsoo Song et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism
- (2018) Qingqiu Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Radiosensitizers
- (2018) Hao Wang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer
- (2018) Robert D. Timmerman et al. JAMA Oncology
- A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis
- (2017) William P Katt et al. Future Medicinal Chemistry
- Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy
- (2017) Motonobu Saito et al. SURGERY TODAY
- Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
- (2017) Ravyn M. Thompson et al. Oncotarget
- Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer
- (2017) Milica Momcilovic et al. Cell Reports
- Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines
- (2016) Daniel R. Sappington et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells
- (2016) Aaron M. Hosios et al. DEVELOPMENTAL CELL
- Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
- (2016) Amira Elgogary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models
- (2015) Nathan A. Koonce et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- (2015) Yan Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors
- (2013) Ajit G. Thomas et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecularly Targeted Therapies in Locally Advanced Non–Small-Cell Lung Cancer
- (2013) Siddhartha Devarakonda et al. Clinical Lung Cancer
- Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
- (2013) Amr Mohamed et al. Clinical Lung Cancer
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Analysis of glutamine dependency in non-small cell lung cancer
- (2012) A. Pieter J. van den Heuvel et al. CANCER BIOLOGY & THERAPY
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Molecular Profiling to Optimize Treatment in Non-Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group
- (2012) Natalie L. Ausborn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors
- (2012) Krupa Shukla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy Agency
- (2011) Yasushi Nagata et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer
- (2010) Corey J. Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
- (2010) Daniel Morgensztern et al. Journal of Thoracic Oncology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started